Deans' stroke musings: Cannabidiol Drives Efficient Neural Differentiation of Human Wharton’s Jelly Mesenchymal Stem Cells: A Small-Molecule Approach for In Vitro Neurogenesis

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Saturday, July 25, 2026

Cannabidiol Drives Efficient Neural Differentiation of Human Wharton’s Jelly Mesenchymal Stem Cells: A Small-Molecule Approach for In Vitro Neurogenesis

Will your competent? doctor conclude that this is worth writing a protocol on to get you better recovery? Or, WILL NOTHING BE DONE, LIKE USUAL?

Of course your incompetent? doctor won't get further research going!

Cannabidiol Drives Efficient Neural Differentiation of Human Wharton’s Jelly Mesenchymal Stem Cells: A Small-Molecule Approach for In Vitro Neurogenesis

Erfan Motalebzadeh 1 , Akram Tajik 2 , Raheleh Halabian 3 , Nafiseh Abbasabadi 4, Hanieh Ahmadi 5, Ali Salimi 6* 1 Department of Biology, Basic Science Faculty, Science and Research Branch, Islamic Azad University, Tehran, Iran 2 Department of Cellular and Molecular Biology, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran 3 Applied Microbiology Research Center, Biomedicine Technologies Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran 4 Department of Biology, Science and Research branch, Islamic Azad University, Tehran, Iran 5 Department of Cell and Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran 6 Tissue Engineering and Regenerative Medicine Research Center, New Health Technologies Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran Corresponding Author: Ali Salimi, PhD, Associate Professor, Tissue Engineering and Tissue Engineering and Regenerative Medicine Research Center, New Health Technologies Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran. Tel: +989128596570, E-mail: salimiali@bmsu.ac.ir Received August 11, 2025; Accepted November 5, 2025; Online Published June 30, 2026

Abstract

Introduction:

Over the past decade, research on small molecules such as cannabidiol (CBD) has expanded due to their ability to modulate biological pathways through protein interactions. Understanding how mesenchymal stem cells (MSCs) differentiate into neural-like cells is crucial for developing effective therapies for neurological disorders. This study aimed to investigate the efficacy of cannabidiol, as a cost effective small-molecule inducer, in promoting the neural differentiation of human Wharton’s jelly MSCs (hWJ-MSCs) in vitro and to determine the optimal non-cytotoxic dose for this purpose.

Materials and Methods:

The optimal CBD dose (5 μg/ml) was first determined using the MTT assay and acridine orange/ethidium bromide (AO/EB) staining. To evaluate neural differentiation potential, the expression of neural marker genes, MAP-2, NSE, Oligo-2, β-tubulin III, and GFAP, was assessed by real-time PCR at 7 and 14 days’ post-induction.

Results:

The results demonstrated significant upregulation of neural marker genes at 7 and 14 days after CBD treatment, confirming successful induction of neural differentiation.

Conclusions:

The designed protocol is highly effective and efficient for inducing neural differentiation. Further in vivo studies using biocompatible scaffolds are necessary to elucidate the underlying mechanisms and therapeutic implications of these findings.

Keywords:

Cannabidiol, Small Molecules, Wharton’s Jelly Mesenchymal Stem Cells, Neural-Like Cells Citation: Motalebzadeh E, Tajik A, Halabian R, Abbasabadi N, Ahmadi H, Salimi A. Cannabidiol Drives Efficient Neural Differentiation of Human Wharton’s Jelly Mesenchymal Stem Cells: A Small-Molecule Approach for In Vitro Neurogenesis. J Appl Biotechnol Rep. 2026;13(2):2080-2088. doi:10.30491/jabr.2025.540602.1903